RSS   Newsletter   Contact   Advertise with us
Post Online Media

Synthorx names Patrick J. Doyle as chief business officer

SynthorxSynthorx, a biotechnology company, announced the appointment of Patrick J. Doyle as chief business officer.
Article continues below

Mr. Doyle has more than 20 years of experience with worldwide business development, licensing and leadership of the pharmaceutical R&D process.

Prior to joining Synthorx, Mr. Doyle held various C-suite positions at Kinemed, Kareus Therapeutics, Syntaxin and Metabolex, where he grew the business platforms significantly via global collaborations and financing.

In addition, he has held top management positions at Novo Nordisk, Roche and PPD.

He completed his Ph.D. thesis and received his B.S. in pharmacology from the University of Sunderland in England.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy